Amalgamated Bank’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,928
Closed -$550K 1719
2018
Q4
$550K Buy
3,928
+2,353
+149% +$357K 0.02% 880
2018
Q3
$269K Sell
1,575
-2,478
-61% -$416K 0.01% 1178
2018
Q2
$703K Buy
4,053
+1,002
+33% +$151K 0.02% 874
2018
Q1
$352K Sell
3,051
-54
-2% -$5.74K 0.01% 1130
2017
Q4
$261K Buy
3,105
+194
+7% +$16.2K 0.01% 1344
2017
Q3
$268K Buy
+2,911
New +$226K 0.01% 1291

Other funds holding LOXO

Amalgamated Bank's LOXO Position: Q1 2019 in Review

Amalgamated Bank sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 3,928 shares — an estimated $550K sold.

Amalgamated Bank first reported a position in LOXO in Q3 2017 and held it in 6 quarters. The position peaked at $703K in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Amalgamated Bank reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Amalgamated Bank sold 3,928 Loxo Oncology, Inc shares in Q1 2019, an estimated $550K.
  • Amalgamated Bank first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 6 quarters.
  • Amalgamated Bank's Loxo Oncology, Inc position peaked at $703K in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Amalgamated Bank's 13F filing for Q1 2019, filed 15 May 2019.